# HepC Micro-elimination on MSM and TGW Population.

> **NCT06847958** · — · COMPLETED · sponsor: **Projecte dels NOMS Hispanosida** · enrollment: 13161 (actual)

## Conditions studied

- Hepatitis C
- PrEP
- Drugs of Abuse

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06847958
- **Lead sponsor:** Projecte dels NOMS Hispanosida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-23
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 13161 (ACTUAL)
- **Last updated:** 2025-02-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06847958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06847958, "HepC Micro-elimination on MSM and TGW Population.". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06847958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*